Author:
Rolnick Sharon J.,Rahm Alanna K.,Jackson Jody M.,Nekhlyudov Larissa,Goddard Katrina A. B.,Field Terry,McCarty Catherine,Nakasato Cynthia,Roblin Douglas,Anderson Christopher P.,Valdez Rodolfo
Reference53 articles.
1. (2009a). Colon Cancer. NCNN clinical practice guidelines in oncology (NCCN GuidelinesTM) Retrieved March 3, 2009, from www.nccn.org .
2. (2009b). Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genetics in Medicine, 11, 35–41
3. Allegra, C. J., Jessup, J. M., Somerfield, M. R., Hamilton, S. R., Hammond, E. H., Hayes, D. F., et al. (2009). American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. Journal of Clinical Oncology, 27, 2091–2096.
4. American Cancer Society. (2006). Minnesota cancer facts and figures 2006. Mendota Heights, American Cancer Society, Midwest Division.
5. American Society of Clinical Oncology. (2003). American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. Journal of Clinical Oncology, 21, 2397–2406.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献